Catalyzing commercial strategies for medical device companies focused on improving the clinician’s toolkit and ecosystem.
▪ Creating Marketing Plans to ensure deliberate organizational goal achievement within new and existing markets, including strategic alignment on customer segmentation, targeting, and positioning, competitive analysis, pricing, product lifecycle, etc
▪ Launch planning, gap analysis, and tactical execution to bring medical devices to market on time and in budget

Led marketing efforts to launch the Accelerated Clinical Trials category and business development for multiple verticals
▪ Developed brand voice and messaging for the new category to resonate in the marketplace
▪ Created iterative Marketing Plan for organizational expansion into additional verticals
▪ Managed new website launch, sales tool development, and conference strategy

Upstream hemodynamic monitoring platform product development including acquired technology integration
▪ Global product launches, including Target Market Releases for MVP technologies, into US, EU, JP, and all major regions globally, growing capital revenues from $30M to $90M and reaching over 1.5M patients annually
▪ Products launched include: HemoSphere Advanced Monitoring Platform, Hypotension Prediction Index (HPI), and iterative sustaining hardware/software improvements

Sold hemodynamic monitoring platforms (capital), service programs, consumable sensors to clinicians and hospital administration to reduce hospitals' economic burdens and improve patient outcomes through perioperative programs
▪ Targeted focus on balancing costs, adopting value-based care, and navigating reimbursement changes

Provide education and case support for OR staff and physicians for the EDWARDS INTUITY Elite device implant procedure under the TRANSFORM Trial to obtain FDA approval

Rotational program technical skills and business acumen through engineering, clinical, and marketing lenses